Source comparison
MOTS-c Dosage Protocol Guide: Administration Method Comparison
The administration route influences bioavailability, onset time, and reproducibility. Most research teams default to the method published in the original paper they're attempting to replicate, but understanding the trade-offs between routes improves protocol d
This comparison does not assign a generated winner or score.
- The administration route influences bioavailability, onset time, and reproducibility. Most research teams default to the method published in the original paper they're attempting to replicate, but understanding the trade-offs between routes improves protocol design.
- Subcutaneous Injection
- 80–90%
- 15–30 minutes
- Consistent absorption kinetics; minimal technical skill required; suitable for repeated dosing; reduced injection site trauma compared to IP
- Requires injection training; potential for injection site reactions with frequent dosing
- Best choice for multi-week studies requiring repeated administration. Predictable plasma curves and low technical failure rate
- Intraperitoneal Injection
- 70–85%
- 10–20 minutes
- Faster systemic distribution; larger volume tolerance; established method in rodent models
- Higher variability in absorption; risk of organ puncture; requires trained personnel
- Appropriate for acute metabolic challenge studies or single-dose experiments; avoid for chronic dosing due to cumulative trauma risk
- Intravenous Injection
- ~100%
- Immediate
- Precise dose delivery; no absorption variability; ideal for pharmacokinetic studies
- Requires tail vein catheterization or surgical vascular access; high technical difficulty; risk of peptide degradation from rapid circulation exposure
- Reserved for PK studies or situations requiring exact plasma concentration control. Not practical for standard metabolic research
- Oral Administration
- <5% (estimated)
- Variable, likely >60 min
- Non-invasive; easy repeated administration
- Extremely low bioavailability due to gastric degradation; unpredictable absorption; no published data supporting efficacy via this route
- Not recommended. MOTS-c contains multiple peptide bonds susceptible to gastric protease degradation; no published research has demonstrated oral bioactivity
- Subcutaneous injection remains the gold standard for MOTS-c dosage protocols requiring repeated administration over multiple weeks. Injection site rotation (alternating between dorsal neck region and flank in rodents; alternating between abdominal quadrants in larger models) prevents localized tissue damage and maintains consistent absorption. Needle gauge selection matters. 27-gauge insulin syringes minimize tissue trauma while allowing accurate delivery of small volumes (0.1–0.5mL typical in rodent studies).